Chlorothiazide sodium
NDC 68083-614, Chlorothiazide sodium, injection, powder, lyophilized, for solution, from Gland Pharma Limited.
- Product NDC
- 68083-614
- Status
- Listed
- Labeler
- Gland Pharma Limited
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218630
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68083-614 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHLOROTHIAZIDE SODIUM500 mg/18mL
Pharmacologic classes
Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68083-614-01 | 68083061401 | 1 VIAL in 1 CARTON (68083-614-01) / 18 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bf921935-9740-458e-b786-69f76d8ad139
Use it
Look up 68083-614 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68083-614 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68083-614. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.